Abstract
Patients with long-standing inflammatory bowel disease (IBD) of the colon are at increased risk of developing colorectal neoplasia (CRN), which is thought to develop along the inflammation-dysplasia-neoplasia sequence. Whereas in the past, a finding of any degree of dysplasia in the setting of IBD colitis was managed with surgery, our ability to manage dysplasia endoscopically with enrollment in an endoscopic surveillance program and/or endoscopic resection has been a major paradigm shift. Successful dysplasia surveillance programs are multidisciplinary and require not only close communication between the gastroenterologist, pathologist, and colorectal surgeon with experience in IBD, but more importantly with the patient to ensure close adherence to follow-up and therapy. Whether our enhanced endoscopic technologies and techniques, as well as improved medical therapies to control inflammation have altered the natural course of CRN in IBD remains to be determined. This chapter focuses on the multimodal management of dysplasia in IBD colitis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol. 2008;14:2662–9.
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.
Andersen NN, Jess T. Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol. 2013;19:7561–8.
Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–81.e1. quiz e13.
Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–45.
Lutgens M, Vermeire S, Van Oijen M, et al. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015;13:148–54.e1.
Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.
Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489–501.e26.
Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–8.
Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746–74. 774.e1.
Voorham QJ, Rondagh EJ, Knol DL, et al. Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis. Am J Gastroenterol. 2013;108:1042–56.
Wanders LK, Dekker E, Pullens B, Bassett P, Travis SP, East JE. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol. 2014;12:756–64.
Iacopini F, Saito Y, Yamada M, et al. Curative endoscopic submucosal dissection of large nonpolypoid superficial neoplasms in ulcerative colitis (with videos). Gastrointest Endosc. 2015;82:734–8.
Magro F, Langner C, Driessen A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7:827–51.
Choi CH, Rutter MD, Askari A, et al. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview. Am J Gastroenterol. 2015;110:1022–34.
Kaltenbach T, Leite G, Soetikno R. Colonoscopy surveillance and management of dysplasia in inflammatory bowel disease. Curr Treat Options Gastroenterol. 2016;14(1):103–14. https://doi.org/10.1007/s11938-016-0072-4.
Kaltenbach T, McQuaid KR, Soetikno R, Laine L. Improving detection of colorectal dysplasia in inflammatory bowel disease surveillance. Gastrointest Endosc. 2016;83:1013–4.
Maser EA, Sachar DB, Kruse D, Harpaz N, Ullman T, Bauer JJ. High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn’s colitis. Inflamm Bowel Dis. 2013;19:1827–32.
Mooiweer E, Oldenburg B. The debate continues over the best method of endoscopic surveillance for colorectal cancer in patients with colitis. Clin Gastroenterol Hepatol. 2015;13:1782–4.
Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;373:195.
Chapman CG, Rubin DT. The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2014;24:353–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Shah, S.C., Torres, J., Itzkowitz, S.H. (2018). Management of Dysplasia in IBD. In: Schlachta, C., Sylla, P. (eds) Current Common Dilemmas in Colorectal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-70117-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-70117-2_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70116-5
Online ISBN: 978-3-319-70117-2
eBook Packages: MedicineMedicine (R0)